Suppression of hypoxia-induced CAV1 autophagic degradation enhances nanoalbumin-paclitaxel transcytosis and improves therapeutic activity in pancreatic cancer.
Bai X, Xiong J, Li L, Yu C, Sun C. Eur J Pharmacol. 2024 Apr 15; 969:176431. Epub 2024 Feb 22.